Vietnam Investment Reviev4h
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
Metastatic Colorectal Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies by DelveInsight
DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...
Science Daily8h
Gene modification could improve cancer treatment's success rate
A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...
Reprogramming compromised immune cells to fight cancer
Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...
AZoLifeSciences on MSN14h
Gene Delivery Systems: Viral vs. Non-Viral Vectors
This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...
Mirror life is a scientific fantasy leading to a dangerous reality − a synthetic biologist explains how mirror bacteria could conquer life on Earth
Synthetic cells that look just like natural cells but are chemically reversed could outcompete other living organisms − with ...
The Cool Down on MSN18h
Scientists make major breakthrough that may curb the threat of Ebola: 'Information we should have'
"If we don't know what the wildlife host is, we can't know how, where or when that will be." Scientists make major ...